Dicerna Pharmaceuticals
Patents, Design & Utilities

Last updated:

List of all Dicerna Pharmaceuticals patents 72 in total

Status Patent
Application
Utility: REDUCING BETA-CATENIN AND IDO EXPRESSION TO POTENTIATE IMMUNOTHERAPY External link
Filling date: 9 Sep 2025 Issue date: 29 Oct 2020
Grant
Utility: Methods for treating hepatitis B infection External link
Filling date: 9 Sep 2025 Issue date: 13 Oct 2020
Application
Utility: METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF KRAS BY ASYMMETRIC DOUBLE-STRANDED RNA External link
Filling date: 9 Sep 2025 Issue date: 8 Oct 2020
Application
Utility: COMPOSITIONS AND METHODS FOR INHIBITING HMGB1 EXPRESSION External link
Filling date: 9 Sep 2025 Issue date: 24 Sep 2020
Application
Utility: METHODS AND COMPOSITIONS FOR INHIBITING EXPRESSION OF LDHA External link
Filling date: 9 Sep 2025 Issue date: 10 Sep 2020
Application
Utility: BETA CATENIN NUCLEIC ACID INHIBITOR MOLECULE External link
Filling date: 9 Sep 2025 Issue date: 27 Aug 2020
Grant
Utility: Methods and compositions for the specific inhibition of KRAS by asymmetric double-stranded RNA External link
Filling date: 9 Sep 2025 Issue date: 25 Aug 2020
Grant
Utility: Therapeutic inhibition of lactate dehydrogenase and agents therefor External link
Filling date: 9 Sep 2025 Issue date: 11 Aug 2020
Grant
Utility: Methods and compositions for the specific inhibition of antithrombin 3 (AT3) by double-stranded RNA External link
Filling date: 9 Sep 2025 Issue date: 23 Jun 2020
Grant
Utility: Methods and compositions for the specific inhibition of transthyretin (TTR) by double-stranded RNA External link
Filling date: 9 Sep 2025 Issue date: 9 Jun 2020
Grant
Utility: Compositions and methods for inhibiting HMGB1 expression External link
Filling date: 9 Sep 2025 Issue date: 9 Jun 2020
Application
Utility: METHODS FOR TREATING HEPATITIS B INFECTION External link
Filling date: 9 Sep 2025 Issue date: 4 Jun 2020
Grant
Utility: Methods and compositions for the specific inhibition of .beta.-catenin by double-stranded RNA External link
Filling date: 9 Sep 2025 Issue date: 7 Apr 2020
Application
Utility: LIGAND-MODIFIED DOUBLE-STRANDED NUCLEIC ACIDS External link
Filling date: 9 Sep 2025 Issue date: 30 Jan 2020
Application
Utility: METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GLYCOLATE OXIDASE (HAO1) BY DOUBLE-STRANDED RNA External link
Filling date: 9 Sep 2025 Issue date: 2 Jan 2020
Application
Utility: METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF APLHA-1 ANTITRYPSIN BY DOUBLE-STRANDED RNA External link
Filling date: 9 Sep 2025 Issue date: 26 Dec 2019
Grant
Utility: Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA External link
Filling date: 9 Sep 2025 Issue date: 26 Nov 2019
Grant
Utility: Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA External link
Filling date: 9 Sep 2025 Issue date: 5 Nov 2019
Application
Utility: THERAPEUTIC INHIBITION OF LACTATE DEHYDROGENASE AND AGENTS THEREFOR External link
Filling date: 9 Sep 2025 Issue date: 24 Oct 2019
Application
Utility: DOUBLE-STRANDED NUCLEIC ACID INHIBITOR MOLECULES MODIFIED WITH TM-INCREASING NUCLEOTIDES External link
Filling date: 9 Sep 2025 Issue date: 17 Oct 2019
Grant
Utility: Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA External link
Filling date: 9 Sep 2025 Issue date: 8 Oct 2019
Grant
Utility: Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded RNA External link
Filling date: 9 Sep 2025 Issue date: 6 Aug 2019

Showing 50 to 72 of 72 patents.